Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer

Radiotherapy and Oncology

Volumn 99, Issue 2, 2011, Pages 193-200

  Souvatzoglou, Michael ^a   Krause, Bernd J ^a   Pürschel, Anja ^b   Thamm, Reinhard ^b   Schuster, Tibor ^b   Buck, Andreas K ^a   Zimmermann, Frank ^b   Molls, Michael ^b   Schwaiger, Markus ^a   Geinitz, Hans ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

11C choline PET CT; Prostate cancer recurrence; Salvage radiotherapy

Indexed keywords

ANDROGEN; CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MALE; PLANNING TARGET VOLUME; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SALVAGE RADIOTHERAPY; TREATMENT PLANNING;

AGED; CARBON RADIOISOTOPES; CHOLINE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79958152808     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.05.005     Document Type: Article

References (41)

1. F.J. Bianco Jr, P.T. Scardino, and J.A. Eastham Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta") Urology 66 2005 Nov 83 94 (Pubitemid 41356564)
2. C.R. Pound, A.W. Partin, M.A. Eisenberger, D.W. Chan, J.D. Pearson, and P.C. Walsh Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597 (Pubitemid 29211767)
3. D. Pasquier, and C. Ballereau Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review Int J Radiat Oncol Biol Phys 72 2008 972 979 Review
4. M.S. Anscher, R. Clough, and R. Dodge Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: The first 10 years Int J Radiat Oncol Biol Phys 48 2000 369 375
5. A. Stephenson, P. Scardino, and M. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041 (Pubitemid 46972788)
6. S.R. Bott Management of recurrent disease after radical prostatectomy Prostate Cancer Prostatic Dis 7 2004 211 216 (Pubitemid 41741505)
7. C.J. Kane, C.L. Amling, and P.A. Johnstone Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy Urology 61 2003 Mar 607 611 (Pubitemid 36294200)
8. 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy J Urol 159 1998 2041 2047 (Pubitemid 29190751)
9. 111In-capromab pendetide (ProstaScint) scan as pre-treatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 67 2007 834 840 (Pubitemid 46215867)
10. M.J. Beresford, D. Gillatt, R.J. Benson, and T. Ajithkumar A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence Clinical Oncology 22 2010 46 55
11. M. Picchio, C. Messa, C. Landoni, and L. Gianolli Value of [11C]choline positron emission tomography for restaging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography J Urol 169 2003 1337 1340 (Pubitemid 36323779)
12. S. Yoshida, K. Nakagomi, S. Goto, M. Futatsubashi, and T. Torizuka 11C choline positron emission tomography in prostate cancer: primary staging and recurrent site staging Urol Int 74 2005 214 220 (Pubitemid 41201531)
13. M. Heinisch, A. Dirisamer, and W. Loidl Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng/ml? Mol Imaging Biol 8 2006 43 48 (Pubitemid 44193401)
14. D.T. Schmid, H. John, and R. Zweifel Fluorocholine PET/CT in patients with prostate cancer: initial experience Radiology 235 2005 623 628 (Pubitemid 40571106)
15. M. Cimitan, R. Bortolus, and S. Morassut [(18)F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Eur J Nucl Med Mol Imaging 33 2006 1387 1398 (Pubitemid 44885404)
16. S.N. Reske, N.M. Blumstein, and G. Glatting [(11)C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy Eur J Nucl Med Mol Imaging 35 2008 9 17 (Pubitemid 350234137)
17. B.J. Krause, M. Souvatzoglou, and M. Tuncel The detection rate of [(11)C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 18 23 (Pubitemid 350234152)
18. A. Heidenreich, G. Aus, and M. Bolla EAU Guidelines on prostate cancer Eur Urol 53 2008 68 80 (Pubitemid 350166735)
19. T. Hara 11C-choline and 2-deoxy-2-[18F]fluoro-d-glucose in tumor imaging with positron emission tomography Mol Imaging Biol 4 2002 267 273 (Pubitemid 35214587)
20. H. Geinitz, F. Zimmermann, R. Thamm, A. Schumertl, R. Busch, and M. Molls 3D conformal radiation therapy for prostate cancer in elderly patients Radiother Oncol 76 2005 27 34 (Pubitemid 41096511)
21. R. Choo, G. Hruby, and J. Hong (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy Int J Radiat Oncol Biol Phys 53 2002 269 276 (Pubitemid 34522092)
22. H. Geinitz, M. Riegel, and R. Thamm Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen after radical prostatectomy Int J Radiat Oncol Biol Phys 2011 10.1016/j.ijrobp.2011.03.003
23. B.J. Trock, M. Han, S.J. Freedland, E.B. Humphreys, T.L. DeWeese, and A.W. Partin Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769 (Pubitemid 351846851)
24. M.G. Harisinghani, J. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491 2499 (Pubitemid 36706536)
25. T. Sella, L.H. Schwartz, and P.W. Swindle Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging Radiology 231 2004 379 385 (Pubitemid 38552892)
26. R. Mirabell, H. Vees, and J. Lozano Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure Int J Radiat Oncol Biol Phys 67 2007 356 361 (Pubitemid 46108320)
27. P. Gibbs, D.J. Tozer, G.P. Liney, and L.W. Turnbull Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate Magn Reson Med 46 2001 1054 1058 (Pubitemid 33104291)
28. M.A. Haider, T.H. van der Kwast, and J. Tanguay Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer Am J Roentgenol 189 2007 323 328 (Pubitemid 47195916)
29. M. Eiber, A.J. Beer, and K. Holzapfel Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging Invest Radiol 45 2010 15 23
30. T.K. Choueiri, R. Dreicer, A. Paciorek, P.R. Carroll, and B. Konety A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy J Urol 179 2008 906 910
31. I.J. de Jong, J. Pruim, P.H. Elsinga, W. Vaalburg, and H.J. Mensink Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET J Nucl Med 44 2003 331 335 (Pubitemid 39586006)
32. 11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer BJU Int 100 2007 786 793 (Pubitemid 47360183)
33. 18F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 253 263
34. J. Kotzerke, B.G. Volkmer, and B. Neumaier Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer Eur J Nucl Med Mol Imaging 29 2002 1380 1384 (Pubitemid 44392221)
35. S. Wachter, S. Tomek, and A. Kurtaran 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer J Clin Oncol 24 2006 2513 2519 (Pubitemid 46630628)
36. H. Vees, F. Buchegger, and S. Albrecht 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy BJU Int 99 2007 1415 1420 (Pubitemid 47164795)
37. V. Scattoni, M. Picchio, and N. Suardi Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429 (Pubitemid 46963456)
38. M.T. Wyss, B. Weber, and M. Honer 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET Eur J Nucl Med Mol Imaging 31 2004 312 316 (Pubitemid 38314073)
39. A. van Waarde, P.L. Jager, K. Ishiwata, R.A. Dierckx, and P.H. Elsinga Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation J Nucl Med 47 2006 150 154 (Pubitemid 46768524)
40. T. Torizuka, T. Kanno, and M. Futatsubashi Imaging of gynecologic tumors: comparison of [11C]choline PET with [18]F-FDG PET J Nucl Med 44 2003 1051 1056 (Pubitemid 39663379)
41. D. Schilling, H.P. Schlemmer, and P.H. Wagner A Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer BJU Int 102 2008 446 451 (Pubitemid 352032836)